Dr. Mel Chua: Evolution of ChemoRT Trials in Nasopharyngeal Carcinoma: A Hobbit's Journey Part 2



In this second part of his lecture, Dr. Chua discusses ongoing trials in NPC, the significance of EBV titers and implications of the EBV vaccine, and his recently published trial in oligometastic NPC, among other topics.

Leave a Reply

Your email address will not be published. Required fields are marked *